Evestia临床诊所获得红十字委员会 -- -- Weyer公司的支持,以促进全球临床试验服务和快速药物开发。 Evestia Clinical acquires ICRC-Weyer to boost global clinical trial services and speed drug development.

埃维斯蒂亚临床公司收购了红十字国际委员会-韦尔,扩大了其全球全方位服务临床研究能力. Evestia Clinical has acquired ICRC-Weyer, expanding its global full-service clinical research capabilities. 此举强化了Evestia在临床试验管理、数据分析以及关键市场监管支持中的存在。 The move strengthens Evestia’s presence in clinical trial management, data analytics, and regulatory support across key markets. 购置的目的是为世界各地的制药和生物技术客户加强提供服务,加快药物开发。 The acquisition aims to enhance service delivery and accelerate drug development for pharmaceutical and biotech clients worldwide.